Author (Corporate) | European Medicines Agency |
---|---|
Series Title | Press Release |
Series Details | 21.02.14 |
Publication Date | 21/02/2014 |
Content Type | News |
The European Medicines Agency's Committee for Medicinal Products for Human use (CHMP) in February 2014 recommended granting a paediatric-use marketing authorisation (PUMA) for Hemangiol for the treatment of proliferating infantile haemangioma. This is the second time that the CHMP has granted a positive opinion for a PUMA since their introduction by the Paediatric Regulation, which came into force in 2007. |
|
Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/02/news_detail_002030.jsp&mid=WC0b01ac058004d5c1 |
Related Links |
|
Subject Categories | Geography, Health |
Countries / Regions | Europe |